Sage Therapeutics (NASDAQ:SAGE) Lowered to Sell Rating by Wall Street Zen
Wall Street Zen cut shares of Sage Therapeutics (NASDAQ:SAGE – Free Report) from a hold rating to a sell rating in a research note issued to investors on Saturday. A number of other research firms have also recently weighed in on SAGE. Needham & Company LLC reaffirmed a “hold” rating on shares of Sage Therapeutics […]
Wall Street Zen cut shares of Sage Therapeutics (NASDAQ:SAGE – Free Report) from a hold rating to a sell rating in a research note issued to investors on Saturday. A number of other research firms have also recently weighed in on SAGE. Needham & Company LLC reaffirmed a “hold” rating on shares of Sage Therapeutics […]
